Brian A. Markison

Insider Reports History

Entity
Individual
Location
501 Fifth Street, Bristol, TN
Signature
/s/ Eric M. Green, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian A. Markison:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lantheus Holdings, Inc. CEO, Director Common Stock 153K $8.45M $55.31 Mar 1, 2024 Direct
RVL Pharmaceuticals plc Chief Executive Officer, Director Ordinary Shares 2.98M $92.9K $0.03 Aug 8, 2022 Direct
Lantheus Holdings, Inc. CEO, Director Stock Option (right to buy) 3.8K May 11, 2023 Direct

Insider Reports Filed by Brian A. Markison

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LNTH Lantheus Holdings, Inc. Mar 1, 2024 1 $0 4 Mar 5, 2024 CEO, Director
LNTH Lantheus Holdings, Inc. May 11, 2023 2 $0 4 May 15, 2023 Director
LNTH Lantheus Holdings, Inc. Mar 27, 2023 1 -$1.08M 4 Mar 29, 2023 Director
LNTH Lantheus Holdings, Inc. Sep 8, 2022 9 -$3.07M 4 Sep 12, 2022 Director
LNTH Lantheus Holdings, Inc. Sep 6, 2022 3 -$99.4K 4 Sep 8, 2022 Director
RVLP RVL Pharmaceuticals plc Aug 8, 2022 1 $1.32M 4 Aug 9, 2022 Chief Executive Officer, Director
LNTH Lantheus Holdings, Inc. May 6, 2022 1 $0 4/A May 12, 2022 Director
RVLP Osmotica Pharmaceuticals plc Nov 4, 2021 1 $0 4 Nov 8, 2021 Chief Executive Officer, Director
LNTH Lantheus Holdings, Inc. May 10, 2021 1 $0 4 May 12, 2021 Director